On the recordApril 24, 2013
I would hope--and I will conclude, Mr. Chairman--that the FDA would consider prioritizing its oversight.
Source
congress.govI would hope--and I will conclude, Mr. Chairman--that the FDA would consider prioritizing its oversight.
Lowey urges the FDA to prioritize oversight of high-risk compounded products.
Share
More from Nita Lowey
Congress has the unique opportunity to support the Administration in creating a new strategy that takes a long-term approach.
We cannot allow a return to a familiar and unstable status quo which repeatedly increases violence and animosity while rendering a final resolution of the conflict impossible.
I am pleased to yield 1 minute to the gentlewoman from Washington (Ms. Schrier).
I urge this Subcommittee to continue its longstanding support for critical people-to-people and peacebuilding programming.